59 related articles for article (PubMed ID: 25429524)
1. Predictors of repeat participation in the NHS bowel cancer screening programme.
Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
Br J Cancer; 2015 Jan; 112(1):199-206. PubMed ID: 25429524
[TBL] [Abstract][Full Text] [Related]
2. High test positivity and low positive predictive value for colorectal cancer of continued faecal occult blood test screening after negative colonoscopy.
Brown JP; Wooldrage K; Wright S; Nickerson C; Cross AJ; Atkin WS
J Med Screen; 2018 Jun; 25(2):70-75. PubMed ID: 28467146
[TBL] [Abstract][Full Text] [Related]
3. Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening.
Raine R; Duffy SW; Wardle J; Solmi F; Morris S; Howe R; Kralj-Hans I; Snowball J; Counsell N; Moss S; Hackshaw A; von Wagner C; Vart G; McGregor LM; Smith SG; Halloran S; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Atkin W
Br J Cancer; 2016 Feb; 114(3):321-6. PubMed ID: 26742011
[TBL] [Abstract][Full Text] [Related]
4. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study.
Palmer CK; Thomas MC; von Wagner C; Raine R
Br J Cancer; 2014 Apr; 110(7):1705-11. PubMed ID: 24619071
[TBL] [Abstract][Full Text] [Related]
5. GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.
Benton SC; Butler P; Allen K; Chesters M; Rickard S; Stanley S; Roope R; Vulkan D; Duffy SW
Br J Cancer; 2017 Jun; 116(12):1551-1557. PubMed ID: 28524157
[TBL] [Abstract][Full Text] [Related]
6. Effects of a modified invitation letter to follow-up colonoscopy for bowel cancer detection.
Travis E; Ashley L; O'Connor DB
Br J Health Psychol; 2024 May; 29(2):379-394. PubMed ID: 37953726
[TBL] [Abstract][Full Text] [Related]
7. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women.
Blanks RG; Benson VS; Alison R; Brown A; Reeves GK; Beral V; Patnick J; Green J
Br J Cancer; 2015 Apr; 112(9):1562-7. PubMed ID: 25742470
[TBL] [Abstract][Full Text] [Related]
8. Enthusiasm for cancer screening in Great Britain: a general population survey.
Waller J; Osborne K; Wardle J
Br J Cancer; 2015 Feb; 112(3):562-6. PubMed ID: 25535731
[TBL] [Abstract][Full Text] [Related]
9. Decomposing socio-economic inequality in colorectal cancer screening uptake in England.
Solmi F; Von Wagner C; Kobayashi LC; Raine R; Wardle J; Morris S
Soc Sci Med; 2015 Jun; 134():76-86. PubMed ID: 25917138
[TBL] [Abstract][Full Text] [Related]
10. Text-message reminders increase uptake of routine breast screening appointments: a randomised controlled trial in a hard-to-reach population.
Kerrison RS; Shukla H; Cunningham D; Oyebode O; Friedman E
Br J Cancer; 2015 Mar; 112(6):1005-10. PubMed ID: 25668008
[TBL] [Abstract][Full Text] [Related]
11. Next-generation strategies for hereditary colorectal cancer risk assessment.
Yurgelun MB
J Clin Oncol; 2015 Feb; 33(5):388-93. PubMed ID: 25559814
[No Abstract] [Full Text] [Related]
12. Subsequent participation in organized FIT based screening following screen-derived colonoscopy
Bülow Therkildsen S; Larsen PT; Njor S
Prev Med Rep; 2023 Apr; 32():102125. PubMed ID: 36816764
[TBL] [Abstract][Full Text] [Related]
13. Mediators of screening uptake in a colorectal cancer screening intervention among Hispanics.
Shokar NK; Salinas J; Dwivedi A
BMC Cancer; 2022 Jan; 22(1):37. PubMed ID: 34983440
[TBL] [Abstract][Full Text] [Related]
14. The integrated screening action model (I-SAM): A theory-based approach to inform intervention development.
Robb KA
Prev Med Rep; 2021 Sep; 23():101427. PubMed ID: 34189020
[TBL] [Abstract][Full Text] [Related]
15. Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests.
Peterse EFP; Meester RGS; de Jonge L; Omidvari AH; Alarid-Escudero F; Knudsen AB; Zauber AG; Lansdorp-Vogelaar I
J Natl Cancer Inst; 2021 Feb; 113(2):154-161. PubMed ID: 32761199
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
Murphy CC; Sen A; Watson B; Gupta S; Mayo H; Singal AG
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):278-287. PubMed ID: 31740521
[TBL] [Abstract][Full Text] [Related]
17. Perceived life expectancy and colorectal cancer screening intentions and behaviour: A population-based UK study.
Dodd RH; Kobayashi LC; von Wagner C
Prev Med Rep; 2019 Dec; 16():101002. PubMed ID: 31709135
[TBL] [Abstract][Full Text] [Related]
18. Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
Osborne JM; Wilson C; Duncan A; Cole SR; Flight I; Turnbull D; Hughes DL; Young GP
BMC Public Health; 2017 Aug; 18(1):81. PubMed ID: 28764667
[TBL] [Abstract][Full Text] [Related]
19. Text-message Reminders in Colorectal Cancer Screening (TRICCS): a randomised controlled trial.
Hirst Y; Skrobanski H; Kerrison RS; Kobayashi LC; Counsell N; Djedovic N; Ruwende J; Stewart M; von Wagner C
Br J Cancer; 2017 May; 116(11):1408-1414. PubMed ID: 28441381
[TBL] [Abstract][Full Text] [Related]
20. Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening.
van der Vlugt M; Grobbee EJ; Bossuyt PM; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Essink-Bot ML; Spaander MC; Dekker E
Br J Cancer; 2017 Jan; 116(1):44-49. PubMed ID: 27923037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
